KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Cash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Inventory (2016 - 2022)

Historic Change in Inventory for TherapeuticsMD (TXMD) over the last 12 years, with Q3 2022 value amounting to $551000.0.

  • TherapeuticsMD's Change in Inventory rose 4972.83% to $551000.0 in Q3 2022 from the same period last year, while for Sep 2022 it was -$588000.0, marking a year-over-year decrease of 200000.0%. This contributed to the annual value of $711000.0 for FY2021, which is 7869.34% down from last year.
  • Per TherapeuticsMD's latest filing, its Change in Inventory stood at $551000.0 for Q3 2022, which was up 4972.83% from -$2.8 million recorded in Q2 2022.
  • TherapeuticsMD's 5-year Change in Inventory high stood at $3.0 million for Q3 2019, and its period low was -$2.8 million during Q2 2022.
  • Moreover, its 5-year median value for Change in Inventory was $497644.0 (2018), whereas its average is $714490.1.
  • As far as peak fluctuations go, TherapeuticsMD's Change in Inventory skyrocketed by 114566.1% in 2019, and later tumbled by 133552.63% in 2022.
  • TherapeuticsMD's Change in Inventory (Quarter) stood at $889449.0 in 2018, then surged by 49.29% to $1.3 million in 2019, then plummeted by 136.07% to -$479000.0 in 2020, then skyrocketed by 154.28% to $260000.0 in 2021, then skyrocketed by 111.92% to $551000.0 in 2022.
  • Its Change in Inventory stands at $551000.0 for Q3 2022, versus -$2.8 million for Q2 2022 and $1.4 million for Q1 2022.